市場調查報告書

人體微生物的全球市場 - 產業洞察,市場趨勢,預測,市場機會分析 2016年∼2024年

Human Microbiome Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

出版商 Coherent Market Insights 商品編碼 785783
出版日期 內容資訊 英文 220 Pages
商品交期: 2-3個工作天內
價格
人體微生物的全球市場 - 產業洞察,市場趨勢,預測,市場機會分析 2016年∼2024年 Human Microbiome Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
出版日期: 2019年01月24日內容資訊: 英文 220 Pages
簡介

人體微生物由於幫助人體的消化,調整免疫系統,可生產血液凝固必要的維他命K,維他命B,維他命B12等維他命,在現代的醫療中發揮很大的作用。C. Difficile感染疾病(CDI)的盛行率的上升成為促進人體微生物市場成長的主要原因

本報告提供人體微生物的世界市場調查,市場概要,各產品類型、併發症、用途、流通管道、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊彙整。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場片段:各產品類型
    • 市場片段:各適應症
    • 市場片段:各用途
    • 市場片段:各流通管道
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 市場趨勢
  • 影響分析
  • 主要的焦點
  • PEST分析
  • 波特的五力分析
  • 合併和收購
  • 法律規範
  • 流行病學

第4章 全球人體微生物市場:各產品類型

  • 簡介
  • 食品
  • 診斷設備/套件
  • 醫藥品
  • 其他

第5章 全球人體微生物市場:各適應症

  • 簡介
  • 消化器官疾病
  • 代謝異常
  • 女性特有的疾病
  • 癌症
  • 其他

第6章 全球人體微生物市場:各用途

  • 簡介
  • 治療
  • 診斷

第7章 全球人體微生物市場:各銷售管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第8章 全球人體微生物市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭環境

  • 熱圖分析
  • 市場佔有率分析
  • 企業簡介
    • Enterome Bioscience
    • Yakult Honsha Co Ltd
    • DuPont
    • AG Metabiomics Corporation
    • ViThera Pharmaceuticals
    • Second Genome Inc.
    • AOBiome LLC
    • Seres Therapeutics
    • uBiome, Inc.
    • Rebiotix, Inc.
    • Synthetic Biologics, Inc.
    • MicroBiome Therapeutics LLC
    • Vedanta BioSciences
    • Osel, Inc.
    • Merck & Co., Inc
  • 分析師的意見

第10章 Section

  • 參考文獻
  • 調查方法
  • 關於Coherent Market Insights
目錄

Human microbiome plays a major role in modern healthcare, as they allow easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12 essential for blood coagulation. Human microbiomes boosts immunity, nutrition, and others.

Market Dynamics

Increasing prevalence of C. Difficile infection (CDI) is a major factor driving human microbiome market growth. In 2010, the American Society for Microbiology, study of CDI over a 13-year period in Quebec, Canada, reported an increase in incidence from 35.6 cases per 100,000 population in 1991 to 156.3 cases per 100,000 population in 2003. According to study published in Clinical Infectious Disease journal in 2015, about 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI. Moreover, introduction of probiotic may induce change in intestinal microbiota and can stabilize microbial communities, which may prevent gut inflammation, propelling growth of the human microbiome market over the forecast period. For instance, in October 2018, BioGaia subsidiary MetaboGen introduced two new strains Faecalibacterium prausnitzii (DSM 32379) and Desulfovibrio piger (DSM 32187) for safety study. These strains are derived from human gut microbiome.

Key features of the study:

  • This report provides in-depth analysis of the human microbiome market and provides market size (US$ 46.913 million) and Compound Annual Growth Rate (CAGR 17.5 %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global human microbiome market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Enterome Bioscience, Yakult Honsha Co., Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc., AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc., and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global human microbiome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the human microbiome market

Detailed Segmentation:

  • Global Human Microbiome Market, By Product Type:
    • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
    • Diagnostic Devices/Kits
    • Drugs
    • Others
  • Global Human Microbiome Market, By Application:
    • Therapeutics
    • Diagnostics
  • Global Human Microbiome Market, By Disease Indication:
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Women Health
    • Cancer
    • Others
  • Global Human Microbiome Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Human Microbiome Market, By Geography:
    • North America
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Enterome Bioscience*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Yakult Honsha Co., Ltd.
    • DuPont
    • AG Metabiomics Corporation
    • ViThera Pharmaceuticals
    • Second Genome Inc.
    • AOBiome LLC
    • Seres Therapeutics
    • uBiome, Inc.
    • Rebiotix, Inc.
    • Synthetic Biologics, Inc
    • MicroBiome Therapeutics LLC
    • Vedanta BioSciences
    • Osel, Inc.
    • Merck & Co., Inc
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Market Trends
  • Impact Analysis
  • Key Highlights
  • PEST Analysis
  • PORTER's Analysis
  • Mergers and Acquisitions
  • Regulatory Framework
  • Epidemiology

4. Global Human Microbiome Market, By Product Type, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Foods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Segment Trends
    • Probiotic
    • Prebiotic
    • Medical Food
  • Diagnostic Devices/Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Human Microbiome Market, By Disease Indication, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Women Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Mn)

6. Global Human Microbiome Market, By Application, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Human Microbiome Market, By Distribution Channel, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Retail Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Online Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Human Microbiome Market, By Region, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016- 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Enterome Bioscience*
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Yakult Honsha Co., Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • DuPont
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AG Metabiomics Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ViThera Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Second Genome Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AOBiome LLC
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Seres Therapeutics
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • uBiome, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rebiotix, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Synthetic Biologics, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MicroBiome Therapeutics LLC
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Vedanta BioSciences
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Osel, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact